Point-of-care testing and antimicrobial resistance
Estimated time for completion: 30 minutes
This module focusses on how antibiotic use leads to anti-microbial resistance (AMR), the expected future economic burden of AMR globally, and actions that can be taken to reduce and reverse AMR, specifically in relation to point-of-care testing (POCT).
All healthcare professionals and coordinators involved in the prescription of antibiotics
- Learn about how and why AMR occurs
- Understand the potential impact of AMR globally
- Explain what actions can be taken to reduce and reverse AMR, relating to POCT specifically
- Understand how AMR relates to C-reactive protein POCT for respiratory tract infections
- Learn about antibiotic stewardship programmes and their impact
- Review relevant case studies and interventions
My Learning Pathway
Point-of-care testing to improve cost-effectiveness of health check programmes in primary care
In our feature article series, we take a look at publications of particular relevance to point-of-care testing (POCT), providing summaries and expert commentary on the key aspects of the paper and within the wider context of POCT systems.
European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
The 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) will bring together more than 14,000 attendees from all over the world, plus experts from relevant fields to present the latest findings and share their expertise.
Sun 26 Sep 2021
Thu 30 Sep 2021
57th Annual Meeting of the European Association for the Study of Diabetes (EASD)
The annual meeting of the European Association for the Study of Diabetes (EASD) is attended by upwards of 20,000 delegates, plus features more than 1,200 talks and presentations on the latest results in diabetes research by leading experts in the field.
Tue 21 Sep 2021
Tue 21 Sep 2021
A one stop shop: the impact of point-of-care lipid testing on cardiovascular disease screening and management
Cardiovascular diseases are a leading cause of death globally, taking 17.9 million lives each year1. Patients at risk of cardiovascular disease (CVD) may show raised blood pressure, have diabetes or have high lipid levels. The good news is, reducing the risk of cardiovascular disease (such as dyslipidemia, hypercholesterolemia and hypertriglyceridemia) is possible with lipid panel tests to identify risk, and continued testing for monitoring.
Fri 03 Sep 2021
Tue 07 Sep 2021
European Respiratory Society (ERS) International congress 2021
The European Respiratory Society International congress (ERS) 2021 will feature a programme covering cover the most recent topics on research and clinical practice, from general pneumology and respiratory intensive care, through to interstitial lung diseases and clinical techniques (see full list of topics here).